IP Library Granted Patent US 10,807,943
Granted Patent B2
US 10,807,943 · App. 15/670,298 · Granted Oct 20, 2020

Non-lactone carbocyclic modulators of bacterial quorum sensing

Inventors: Helen E. Blackwell (Middleton, WI); Christine E. McInnis (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C07C233/11A01N37/22A01N37/42A01N43/08A01N43/10A01N43/38A01N43/56A61K31/164A61K31/165A61K31/167A61K31/22A61K31/221A61K31/245A61K31/341A61K31/381A61K31/404A61K31/405A61K31/415A61K45/06C07C233/10C07C233/51C07C235/34C07C235/80C07C323/62C07D209/18C07D231/40C07D307/52C07D333/36C07D409/12C07C2601/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,807,943
App. No.
15/670,298
Granted
Oct 20, 2020
Kind
B2
Abstract

Non-lactone carbocyclic modulators of bacterial quorum sensing. Pharmaceutical composition containing such modulators. Methods employing such modulators for modulation of quorum sensing. Compounds are exemplified by those of formula: A-[Z] n -L1-[Y]—NH-L2-HG, where A is an optionally substituted aryl or heteroaryl group having one or two 5- or 6-member rings with up to 1-3 heteroatoms in a ring, or a substituted or unsubstituted C1-C12 acyclic aliphatic group and HG is an optionally substituted cyclopentyl group. Compounds include those where n is 1 or 0, Z is —CO—, —O—CO—, —CO—O—, —NH—CO—, —CO—NH—, —NH—CO—NH—, —O—, —S—, or —NH 2 , Y is —NH—CO—, —CO—CH 2 —C(Y1)-, or —SO 2 —, where Y1 is —OH, —SH, —NH 2 or —F; and L1 and L2 independently are —[CH 2 ]p1- and —[CH 2 ]p2-, where p1 and p2, independently, are 0 or integers ranging from 1-3.

Claims (20)

1. A compound of formula I:

A-[Z] n -L1-[Y]—NH-L2-HG

or a pharmaceutically acceptable salt thereof

wherein:

n is 0 and Z is absent;

Y is —CO—CH 2 —CO—;

L1 and L2 independently are —[CH 2 ] p1 — and —[CH 2 ] p2 —, where p1 and p2, independently, are 0 or integers ranging from 1-3;

A is an alkyl or alkenyl group having 4-10 carbon atoms; and

HG is an unsubstituted cyclopentyl group.

2. The compound or salt of claim 1 , wherein A is an alkyl group having 4-10 carbon atoms.

3. The compound or salt of claim 1 , wherein A is an alkenyl group having 4-10 carbon atoms.

4. The compound or salt of claim 1 , wherein p1 and p2 are 0.

5. The compound or salt of claim 1 of formula:

6. The compound of claim 1 , wherein p1 and p2 are integers ranging from 1-3.

7. A pharmaceutical composition comprising an amount of a compound of claim 1 effective for modulation of quorum sensing in a quorum sensing bacterium.

8. A pharmaceutical composition comprising an amount of a compound of claim 5 effective for modulation of quorum sensing in a quorum sensing bacterium.

9. A method for modulating quorum sensing bacteria comprising the step of contacting a quorum sensing bacteria with an amount of a compound of claim 1 effective for modulation of quorum sensing.

10. The method of claim 9 , wherein the quorum sensing bacteria are Pseudomonas aeruginosa.

11. A method for modulating quorum sensing bacteria comprising the step of contacting a quorum sensing bacteria with an amount of a compound of claim 5 effective for modulation of quorum sensing.

12. The method of claim 11 , wherein the quorum sensing bacteria are Pseudomonas aeruginosa.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 18, 2017
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043603/0944 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2017
From: BLACKWELL, HELEN; MCINNIS, CHRISTINE
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 043322/0093 →
Continuity (4)
Continuation 14104235 · Dec 12, 2013
Continuation 12822929 · Jun 24, 2010
Provisional Application 61222075 · Jun 30, 2009
Related Publication 20170334835A1 · Nov 23, 2017